Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Man Liu, Jingying Zhou, Xiaoyu Liu, et al.
Gut (2019) Vol. 69, Iss. 2, pp. 365-379
Closed Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu, Shanshan Liu, Shan Zeng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 337
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donné, Amaia Lujambio
Hepatology (2022) Vol. 77, Iss. 5, pp. 1773-1796
Closed Access | Times Cited: 311
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Kyoko Oura, Asahiro Morishita, Joji Tani, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5801-5801
Open Access | Times Cited: 301
The BET family in immunity and disease
Nian Wang, Runliu Wu, Daolin Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 208
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 179
Inflammatory Mechanisms of HCC Development
Maria Grazia Refolo, Caterina Messa, Vito Guerra, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 641-641
Open Access | Times Cited: 152
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 123
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Chen Chen, Zehua Wang, Yi Ding, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 122
Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
Xiaopei Hao, Guangshun Sun, Yao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 110
Regulatory cells and the effect of cancer immunotherapy
María Iglesias-Escudero, Noelia Arias-González, Eva Martínez‐Cáceres
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 108
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
Weiqin Yang, Yu Feng, Jingying Zhou, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 588
Closed Access | Times Cited: 106
Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation
Xuezhen Zeng, Guanrui Liao, Shumin Li, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1122-1138
Closed Access | Times Cited: 95
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 93
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
Zhewen Xiong, Stephen L. Chan, Jingying Zhou, et al.
Gut (2023) Vol. 72, Iss. 9, pp. 1758-1773
Open Access | Times Cited: 53
Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
Yang Zhao, Junfeng Du, Xiaofei Shen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 41
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
Maite G. Fernández‐Barrena, María Arechederra, Leticia Colyn, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100167-100167
Open Access | Times Cited: 90
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
Yanna Lei, M Kellis, Qian Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 75
Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny
Jianpeng Sheng, Junlei Zhang, Lin Wang, et al.
Gut (2021) Vol. 71, Iss. 6, pp. 1176-1191
Closed Access | Times Cited: 74
Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma
Qianhui Xu, Yuxin Wang, Wen Huang
International Immunopharmacology (2021) Vol. 92, pp. 107333-107333
Closed Access | Times Cited: 73
Circadian regulation of cancer cell and tumor microenvironment crosstalk
Wenjing Xuan, Fatima Khan, C. David James, et al.
Trends in Cell Biology (2021) Vol. 31, Iss. 11, pp. 940-950
Open Access | Times Cited: 73
Black Phosphorus Nanosheet with High Thermal Conversion Efficiency for Photodynamic/Photothermal/Immunotherapy
Danyang Xu, Jun Liu, Yanxing Wang, et al.
ACS Biomaterials Science & Engineering (2020) Vol. 6, Iss. 9, pp. 4940-4948
Closed Access | Times Cited: 70
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target
Chi Ma, Qianfei Zhang, Tim F. Greten
Cellular Immunology (2021) Vol. 361, pp. 104295-104295
Open Access | Times Cited: 58
Epigenetic remodelling in human hepatocellular carcinoma
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top